Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | MLYCD | O95822 | 1/20 | 0.32 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10141004 | 0.87 | LMNA (0.35) | FDPSLMNAKMT2AMEN1NPC1 | |
| SCHEMBL14853086 | 0.74 | FDPS (0.38) | FDPSLMNAKMT2AMEN1NPC1 | |
| SCHEMBL18117397 | 0.74 | FDPS (0.38) | FDPSLMNAKMT2AMEN1NPC1 | |
| SCHEMBL18994931 | 0.72 | FDPS (0.41) | FDPSLMNAKMT2AMEN1NPC1 | |
| SCHEMBL27980070 | 0.72 | FDPS (0.41) | FDPSLMNAKMT2AMEN1NPC1 | |
| SCHEMBL25647654 | 0.71 | FDPS (0.40) | FDPSLMNAKMT2AMEN1NPC1 | |
| Hydrochloric Acid SCHEMBL25222775 | 0.70 | FDPS (0.39) | FDPSLMNAKMT2AMEN1NPC1 | |
| SCHEMBL690630 | 0.69 | ITGA4 (0.43) | FDPSLMNAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL690631 | 0.69 | ITGA4 (0.43) | FDPSLMNAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL3396713 | 0.67 | OPRK1 (0.46) | FDPSLMNAKMT2AMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010099527-A1 | HEPATITIS C VIRUS INHIBITORS | ENANTA PHARMACEUTICALS, INC. (US) | 2010-09-02 | — | — | WO | disclosed |